Stock Events

Stock Events

Disc Medicine 

$58.52
22
+$0+0% Monday 04:17

Statistics

Day High
58.52
Day Low
58.52
52W High
-
52W Low
-
Volume
4
Avg. Volume
-
Mkt Cap
2.21B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Q4 2025
Next
-1.77
-1.66
-1.55
-1.44
Expected EPS
-1.645008
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-424.37MNet Income

Analyst Ratings

$101.00Average Price Target
The highest estimate is 125.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IRON.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a technology that could compete with Disc Medicine's treatments for blood disorders.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals develops treatments for cystic fibrosis and other serious diseases, including blood disorders, potentially competing with Disc Medicine.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences has a broad portfolio including treatments for HIV, liver diseases, and hematology, directly competing with Disc Medicine's focus.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on human therapeutics, including treatments for blood disorders, making it a competitor.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals develops medicines for serious medical conditions, including hematologic conditions, competing with Disc Medicine.
Novartis
NVS
Mkt Cap237.61B
Novartis offers a wide range of healthcare solutions, including treatments for blood disorders, directly competing with Disc Medicine.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical focuses on rare genetic diseases, some of which involve hematologic disorders, making it a competitor.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics works on genomic medicines, including gene-edited cell therapies for blood disorders, competing with Disc Medicine.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals is pioneering RNA interference (RNAi) therapeutics, which could target similar diseases as Disc Medicine.

About

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Show more...
CEO
ISIN
US2546041011

Listings

XNAS
US
IRON
BOATS
BOATS
IRON.BOATS

0 Comments

Share your thoughts

FAQ

What is Disc Medicine stock price today?▼
The current price of IRON.BOATS is $58.52 USD — it has increased by +0% in the past 24 hours. Watch Disc Medicine stock price performance more closely on the chart.
What is Disc Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Disc Medicine stocks are traded under the ticker IRON.BOATS.
What is Disc Medicine market cap?▼
Today Disc Medicine has the market capitalization of 2.21B
When is the next Disc Medicine earnings date?▼
Disc Medicine is going to release the next earnings report on May 07, 2026.
What were Disc Medicine earnings last quarter?▼
IRON.BOATS earnings for the last quarter are -1.64 USD per share, whereas the estimation was -1.71 USD resulting in a +4.08% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Disc Medicine revenue for the last year?▼
Disc Medicine revenue for the last year amounts to 0 USD.
What is Disc Medicine net income for the last year?▼
IRON.BOATS net income for the last year is -424.37M USD.
When did Disc Medicine complete a stock split?▼
Disc Medicine has not had any recent stock splits.